Retinal Biologics Market Introduction & Size Analysis:
Retinal biologics are bioengineered substances administered directly into the eyes to treat persistent retinal disorders. These biologics are typically derived from living organisms, such as microbes, animal cells, or plant cells. Notable examples include Eylea, Lucentis, Humira, and Macugen. The global rise in retinal disorders, such...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian